Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited, commonly referred to as Remus Pharma, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2001, the company has made significant strides in developing innovative healthcare solutions, focusing on areas such as cardiology, neurology, and critical care. With a commitment to quality and efficacy, Remus Pharmaceuticals offers a diverse range of products, including prescription medications and over-the-counter solutions, distinguished by their rigorous research and development processes. The company has achieved notable recognition in the market, positioning itself as a trusted name in the healthcare sector. Operating across various regions, Remus Pharma continues to expand its footprint, driven by a dedication to improving patient outcomes and advancing medical science.
DitchCarbon Score
How does Remus Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Remus Pharmaceuticals Limited's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Remus Pharmaceuticals Limited's reported carbon emissions
Remus Pharmaceuticals Limited, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is essential to highlight the company's commitment to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been documented, indicating a potential area for development in their sustainability strategy. As the pharmaceutical industry increasingly prioritises environmental responsibility, Remus Pharmaceuticals may benefit from establishing clear emissions reduction goals and aligning with industry standards to enhance its climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Remus Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
